Information about GlobalPharmacyMeds.to
List of countries where we can ship Cladribine:
Latest news releases on Cladribine:
Cladribine is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis) and B-cell chronic lymphocytic leukemia. Its chemical name is 2 ...
Cladribine official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.
Cladribine is an adenosine deaminase inhibitor with an IC50 of about 0.2 μM. Find all the information about Cladribine for cell signaling research.
Background Cladribine provides immunomodulation through selective targeting of lymphocyte subtypes. We report the results of a 96-week phase 3 trial of a short-course ...
1. N Engl J Med. 2010 May 6;362(18):1738; author reply 1739-40. doi: 10.1056/NEJMc1002550. Oral cladribine and fingolimod for relapsing multiple sclerosis.
Moved Permanently. The document has moved here.
Cladribine Injection, USP (also commonly known as 2-chloro-2’-deoxy-ß-D-adenosine) is a synthetic antineoplastic agent for continuous intravenous infusion.
Cladribine Injection (also commonly known as 2-chloro-2΄-deoxy- β -D-adenosine) is a synthetic antineoplastic agent for continuous intravenous infusion.
Cladribine is an adenosine deaminase-resistant analogue of deoxyadenosine with antilymphocytic effects. The small molecule prodrug is highly effective in
Cladribine is a new drug treatment under investigation for relapsing remitting multiple sclerosis. Read more about cladribine in this A-Z entry.